Download:
pdf |
pdf8876
Federal Register / Vol. 73, No. 32 / Friday, February 15, 2008 / Notices
objectives in Healthy People 2010, an
initiative of the U.S. Department of
Health and Human Services (HHS). The
YRBS provides data to measure at least
10 of the health objectives and 3 of the
10 Leading Health Indicators
established by Healthy People 2010. In
addition, the YRBS can identify racial
and ethnic disparities in health risk
behaviors. No other national source of
students attending public and private
schools in grades 9–12. Information
supporting the YRBS also will be
collected from school administrators
and teachers. The table below reports
the number of respondents annualized
over the 3-year project period.
There are no costs to respondents
except their time.
data measures as many of the Healthy
People 2010 objectives addressing
adolescent behaviors as the YRBS. The
data also will have significant
implications for policy and program
development for school health programs
nationwide.
In Spring 2009 and Spring 2011, the
YRBS will be conducted among
nationally representative samples of
ESTIMATED ANNUALIZED BURDEN HOURS
Type of
respondents
Form name
Administrators ...............
Students ........................
Recruitment Script for the Youth Risk Behavior
Survey.
Data Collection Checklist for the Youth Risk Behavior Survey.
Youth Risk Behavior Survey ................................
Total .......................
..............................................................................
Teachers .......................
Dated: February 7, 2008.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E8–2832 Filed 2–14–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
rwilkins on PROD1PC63 with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960, send
comments to Maryam I. Daneshvar, CDC
Acting Reports Clearance Officer, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
15:58 Feb 14, 2008
Jkt 214001
30/60
115
400
1
15/60
100
8,000
1
45/60
6,000
........................
........................
........................
6,215
National Blood Lead Surveillance
System (OMB No. 0920–0337)—
Revision—National Center for
Environmental Health (NCEH),
Coordinating Center for Environmental
Health and Injury Prevention (CCEHIP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The National Blood Lead Surveillance
System (NBLSS) would like to continue
its effort to collect information related to
lead exposure among children less than
six years old. The overarching goal of
this system is to establish Childhood
Lead Surveillance Systems at the state
and national levels. This is a revision
request in addition to a 3-year revision
with an increase in the burden hours
and inclusion of the adult blood lead
surveillance system. As part of this
effort we would like to revise this
application to include 3 additional State
and local Childhood Lead Poisoning
Prevention Programs (CLPPP) who
report to the NBLSS. These three
programs were added to help provide a
more comprehensive picture of
Frm 00033
Fmt 4703
Total burden
(in hours)
1
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
PO 00000
Average
burden per
response
(in hours)
230
Proposed Project
[60Day–08–0337]
VerDate Aug<31>2005
Number of
responses per
respondent
Number of
respondents
Sfmt 4703
childhood lead poisoning in the United
States.
The objectives for developing this
system are three-fold. First, we would
like to use surveillance data to estimate
the extent of elevated blood-lead levels
(BLLs) among children less than 6 years
old. This is important because it will
allow us to systematically track the
management and follow-up of those
children found to be poisoned with
lead.
Our next objective for the
development of this system is to
examine potential sources of lead
exposure. Although we’ve been
successful in eliminating atmospheric
lead with the use of unleaded gasoline
and have continued to make strides in
the elimination of household sources of
lead commonly found in paint and dust,
recent events have highlighted other
potentially hidden sources of lead. This
system will allow us to track the burden
of such hidden sources and will help us
eliminate such threats with the
establishment of laws aimed at
preventing the importation of such
goods into our nation. The
establishment of such laws will of
course be a joint effort between several
federal agencies; however, this
surveillance system will help facilitate
our efforts.
The final objective of this system is to
facilitate the allocation of resources for
lead poison prevention activities. The
allocation of federal resources to State
surveillance systems are based on
reports of blood-lead tests from
laboratories. Ideally, laboratories report
results of all lead tests to the state health
department. State health departments
E:\FR\FM\15FEN1.SGM
15FEN1
8877
Federal Register / Vol. 73, No. 32 / Friday, February 15, 2008 / Notices
then send reports to CDC using deidentified data. It is from these reports
that CDC is able to determine funding
levels.
In addition to reporting child blood
lead levels, many laboratories also
report adult blood lead levels. Thus, this
OMB request would also like to include
the Adult Blood Lead Epidemiology and
Surveillance Program (ABLES). The
ABLES Program is a state-based
surveillance system under which
participating States provide information
to CDC’s National Institute for
Occupational Safety and Health
(NIOSH) on laboratory reported blood
lead levels among adults. For all adults
(16 and older) the State will provide
data on all laboratory reports when the
adult’s blood lead level is equal to or
greater than 25 mcg/dl. These data are
to be consolidated into a single data
submission by task time periods.
The ABLES program ultimately aims
to collect the complete list of variables
for all blood lead tests, including blood
lead levels less than 25 mcg/dl, and
urges all States to progressively supply
this information as it becomes available.
All data submissions must be delivered
in the supplied format providing a field
for 20 variables, even if some variables
have no data available at the time.
The use of both Childhood Lead
Surveillance System and the ABLES
Program will allow us to systematically
track pockets of exposure to lead. It will
also allow us to fully understand
exposure potential and ways in which
to prevent future sources of lead
poisoning. Both systems are invaluable
and will no doubt help us as we
continue our stride in the elimination of
lead poisoning in our nation.
There is no cost to respondents other
than their time.
ESTIMATED ANNUALIZED BURDEN TABLE
Average
burden per
response
(in hrs.)
Total burden
hours
State and Local Health Departments for Child Surveillance ...........................
State and Local Health Departments for Adult Surveillance ...........................
42
40
4
4
2
2
336
320
Total ..........................................................................................................
........................
........................
........................
656
Dated: February 6, 2008.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E8–2836 Filed 2–14–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10242, CMS–
10165, CMS–10251, CMS–R–218 and CMS–
10252]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS), Department of Health
and Human Services, is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the Agency’s function;
(2) the accuracy of the estimated
AGENCY:
rwilkins on PROD1PC63 with NOTICES
Number of
response per
respondent
Number of
respondents
Respondents
VerDate Aug<31>2005
15:58 Feb 14, 2008
Jkt 214001
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: New collection; Title of
Information Collection: Revisions to
Payment Policies Under the Physician
Fee Schedule, Other Changes to
Payment Under Part B, and Revisions to
Payment Policies for Ambulance
Services for CY 2008 (42 CFR 424.36—
Signature Requirements); Use: Section
42 CFR 424.33(a)(3) states that all claims
must be signed by the beneficiary or the
beneficiary’s representative (in
accordance with 42 CFR 424.36(b)).
Section 42 CFR 424.36(a) states that the
beneficiary’s signature is required on a
claim unless the beneficiary has died or
the provisions of 424.36(b), (c), or (d)
apply. The statutory authority requiring
a beneficiary’s signature on a claim
submitted by a provider is located in
section 1835(a) and in 1814(a) of the
Social Security Act (the Act), for Part B
and Part A services, respectively. The
authority requiring a beneficiary’s
signature for supplier claims is implicit
in sections 1842(b)(3)(B)(ii) and in
1848(g)(4) of the Act. Because it is very
difficult to obtain a beneficiary’s
signature (or the signature of a person
authorized to sign on behalf of the
beneficiary) on a claim when the
beneficiary is being transported by
ambulance in emergency situations,
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
CMS is proposing that, for emergency
ambulance transport services, an
ambulance provider or supplier may
submit the claim without a beneficiary’s
signature, as long as certain
documentation requirements are met.
The information collected will be used
by CMS contractors (both, fiscal
intermediaries and carriers) that process
and pay emergency ambulance transport
claims. Form Number: CMS–10242
(OMB#: 0938–New); Frequency:
Reporting: Hourly, Daily, Weekly,
Monthly and Yearly; Affected Public:
Business or other for-profit and Not-forprofit institutions; Number of
Respondents: 9,000; Total Annual
Responses: 6,500,000; Total Annual
Hours: 541,667.
2. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Electronic
Health Record; Use: The purpose of this
demonstration project is to reward the
delivery of high-quality care supported
by the adoption and use of electronic
health records in small to medium-sized
primary care physician practices. While
this is separate and distinct from the
Medicare Care Management
Performance (MCMP) Demonstration, it
expands upon the foundation created by
the MCMP Demonstration, which was
mandated by Section 649 of the
Medicare Prescription Drug,
Improvement and Modernization Act of
2003. The electronic health record
demonstration will be operational for a
5-year period and will be operated
E:\FR\FM\15FEN1.SGM
15FEN1
File Type | application/pdf |
File Title | Document |
Subject | Extracted Pages |
Author | U.S. Government Printing Office |
File Modified | 2008-02-15 |
File Created | 2008-02-15 |